AstraZeneca enters a licensing agreement with Sino Biopharmaceutical covering a respiratory drug candidate for chronic obstructive pulmonary disease (COPD), according to reports. Under the deal, AstraZeneca pays Sino Biopharmaceutical $200 million upfront. Additional payments are structured around development and commercial milestones, with the total deal value reported at up to $1.9 billion. The disclosures emphasize the upfront consideration and the potential for further milestone-based payments, rather than changes to existing therapies or trial outcomes. The agreement reflects AstraZeneca’s focus on expanding its respiratory pipeline through external assets, while Sino Biopharmaceutical gains near-term funding tied to the licensed program’s progress. Terms beyond the disclosed payment structure, including timelines, geographic rights, and specific regulatory or commercial milestones, are not detailed in the provided excerpts. Overall, the sources agree on the key economic terms: the $200 million upfront payment and potential milestone payments bringing the deal’s value to as much as $1.9 billion.
AstraZeneca to Pay $200M Upfront for Sino Biopharmaceutical Respiratory Drug License
AstraZeneca enters a licensing agreement with Sino Biopharmaceutical covering a respiratory drug candidate for chronic obstructive pulmonary disease (COPD), according to reports. Under the deal, Astra...
- AstraZeneca and Sino Biopharmaceutical sign a respiratory drug licensing agreement.
- The program is for a COPD drug candidate.
- AstraZeneca pays Sino Biopharmaceutical $200 million upfront.
- Sino Biopharmaceutical is eligible for additional milestone payments.
- Reported total deal value reaches up to $1.9 billion.
Sino Biopharmaceutical will receive $200 million upfront from AstraZeneca, and will be eligible for milestone payments.
1 month ago
Irish couple found dead in Spanish villa hot tub after suspected accident
An Irish woman and her husband are found dead in a jacuzzi at a holiday villa in Spain, with police saying foul play is...
Olivia Street named Little Telethon Star for Collagen VI Myopathy and scoliosis
Little Telethon Stars 2026 features Olivia Street, highlighting her life as a child living with Collagen VI Myopathy and...
Nepal flash floods death toll rises; thousands reported missing across affected districts
Nepal’s flash floods and related landslides kill hundreds of people, with multiple outlets reporting that the death toll...